SavedAdd your journal

Journals / Damar Cerrahi Dergisi / 2014 / Cilt: 23 - Sayı: 1

Antifosfolipid sendromlu genç erkek hastada derin ven trombozu ve arteriyel trombozun kombine tedavisi

Combined treatment of both arterial and deep venous thrombosis in a young adult with antiphospholipid syndrome: case report

Özcan GÜR
Volkan YÜKSEL
Selami GÜRKAN
Serhat HÜSEYİN
Suat CANBAZ
Pages
50–52
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, we describe a rare case of both venous and arterial thromboembolic event in a 25-year-old young male age who had surgical treatment with medical treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Antiphospholipid syndrome (APS) is an autoimmune hypercoagulability syndrome that induces a wide variety of thromboembolic events.
📊
Key Findings & Data:Deep venous thrombosis is complicated by pulmonary embolism and infarction in 35% of cases.
💡
Conclusion & Impact:In this paper, we describe a rare case of both venous and arterial thromboembolic event in a 25-year-old young male age who had surgical treatment with medical treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Antiphospholipid syndrome (APS) is an autoimmune hypercoagulability syndrome that induces a wide variety of thromboembolic events. Deep venous thrombosis is complicated by pulmonary embolism and infarction in 35% of cases. The clinical manifestations of the syndrome include venous and arterial thromboses and embolisms, disseminated large and small vessel thromboses with accompanying multiorgan ischemia and infarction, premature coronary artery disease, stroke and pregnancy losses. In this paper, we describe a rare case of both venous and arterial thromboembolic event in a 25-year-old young male age who had surgical treatment with medical treatment.

Özet

Antifosfolipid sendromu değişik tromboembolik olaylara sebep olabilen, otoimmün hiperkoagülabilite sendromudur. Olguların %35inde pulmoner emboli ve infarktla komplike olabilen derin ven trombozu görülebilir. Hastalığın klinik görünümleri arasında; venöz ve arteriyel trombozlarla birlikte emboliler, multiorgan iskemisi ve infarktına neden olabilen küçük ve yaygın büyük damar trombozları, prematür koroner arter hastalığı, strok ve düşükler sayılabilir. Bu yazıda 25 yaşındaki genç erkek hastada görülen arteriyel ve venöz trombozu ile cerrahi ve medikal tedavi birlikteliğini sunduk

🔖

Cite This Article

GÜR, Ö., YÜKSEL, V., GÜRKAN, S., HÜSEYİN, S., CANBAZ, S. (2022). Antifosfolipid sendromlu genç erkek hastada derin ven trombozu ve arteriyel trombozun kombine tedavisi. Damar Cerrahi Dergisi, Cilt: 23 - Sayı: 1, 50–52. https://ajindex.com/articles/486728

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332(15):993-7.
  2. Galli M, Barbui T. Antiphospholipid antibodies and thrombosis: strength of association. He- matol J 2003;4(3):180-6.
  3. Robertson B, Greaves M. An tiphospholipid syndrome: an evolving story. Blood Rev 2006;20(4):201-12.
  4. Mutlu LC, Türker G, Gülbaş G, Yıldırım Z, Ay- doğdu İ. Nadir bir hemoptizi nedeni: antifosfo- lipid antikor sendromu. Solunum Hastalıkları 2004;15:43-6. Hughes GR. The antiphospholipid syndrome: ten years on. Lancet 1993;342(8867):341-4.
  5. Gündoğdu F, Ünlü Y, Barış N, Ars lan S. Antip- hospho lipid antibody syndrome leading to massive pulmonary embolism and sudden de- ath. Arch Turk Soc Cardiol 2008;36(7):467-9. Rand JH. Molecular pathogenesis of the an- tiphospholipid syndrome. Circ Res 2002;90(1): 29-37.
  6. Alarcon Segovia D, Osmundson PJ. Periphe- ral vascular syndromes associated with sys- temic lupus erythematosus. Ann Intern Med 1965;62:907-19.
  7. Bird AG, Lendrum R, Asherson RA, Hughes GR. Disseminated intravascular coagulation, antiphospholipid antibodies, and ischa emic necrosis of extremities. Ann Rhe um Dis 1987;46(3):251-5.
  8. Drew P, Asherson RA, Zuk RJ, Goodwin FJ, Hughes GR. Aortic occlusion in systemic lu - pus erythematosus associated with antip - hospholipid antibodies. Ann Rheum Dis 1987;46(8):612-6.
  9. Shortell CK, Ouriel K, Green RM, Conde mi JJ, DeWeese JA. Vascular disease in the antip- hospholipid syndrome: a comparison with the patient popu lation with atherosclerosis. J Vasc Surg 1992;15(1):158-65. Khamashta MA. Management of thrombosis in the antiphospholipid syndrome. Hughes’ syndrome. London: Springer; 2000. p.391-6.